Drug Development Archives - Oncology Central Oncology Central

i
i

27 Aug 2019 Journal Articles
The rise of oncology biosimilars: from process to promise
15 Aug 2019 Brain and neurologic
Drug-inducible gene therapy for glioblastoma shows promise in clinical trial
8 Aug 2019 Lung
Pembrolizumab receives the green light from NICE for NSCLC subtype
2 Aug 2019 Journal Articles
Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC: updated analysis of the observational GioTag study
24 Jul 2019 News
PARP inhibitors: study uncovers novel mechanism of action
17 Jul 2019 Journal Articles
MONALEESA clinical program: a review of ribociclib use in different clinical settings
15 Jul 2019 Videos
Improving clinical trial success with Carla Balch
12 Jul 2019 Breast
Palbociclib and crizotinib combination could overcome tumor treatment resistance
10 Jul 2019 Videos
Enhancing the efficacy of clinical trials with Jeffery Edenfield
9 Jul 2019 Colorectal
Triple drug combination improves survival in advanced bowel cancer patients
2 Jun 2019 Breast
ASCO19: ribociclib combined with endocrine therapy increases survival in breast cancer patients
23 May 2019 Opinion
ASCO 2019: what should you look out for?